Postoperative duplex ultrasonography screening after total hip arthroplasty
has been shown to identify patients who may require treatment or additiona
l monitoring for venous thromboembolic disease. The potential for manifesta
tion of venous thromboembolic disease subsequent to screening remains a con
cern. The objective of this study was to determine the prevalence of sympto
matic venous thromboembolic disease after total hip arthroplasty and after
inhospital prophylaxis, inhospital screening with negative results for prox
imal deep venous thrombosis, and no posthospitalization venous thromboembol
ic disease prophlaxis. One hundred fifty patients undergoing primary hybrid
total hip arthroplasty and using pneumatic compression stockings and aspir
in as prophylaxis against venous thromboembolic disease were screened for d
eep venous thrombosis with duplex ultrasonography on the fourth day after s
urgery. Duplex ultrasonography screening revealed 17 (11.3%) patients with
asymptomatic proximal deep venous thrombosis. In response to duplex ultraso
nography screening, these patients with proximal deep venous thrombosis rec
eived therapeutic anticoagulation, Of 133 patients with a duplex screen wit
h negative results for proximal deep venous thrombosis, 131 (98.5%) continu
ed to have no symptoms of venous thromboembolic disease and two (1.5%) bega
n to hare symptoms for venous thromboembolic disease (one with proximal dee
p venous thrombosis, one with nonfatal pulmonary embolism) during IZ months
of clinical followup after total hip arthroplasty. The overall prevalence
of venous thromboembolic disease requiring anticoagulation was 19 of 150 (1
2.6%) patients, The remaining 131 (87.4%) were not exposed to the risks of
postoperative anticoagulation and did not have subsequent symptomatic venou
s thromboembolic disease.